Prognostic factors in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 47, Issue 11, 2006, Pages 2261-2262

  Hamblin, Terry ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD23 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 8; LIPOPROTEIN LIPASE; PROTEIN KINASE ZAP 70; THROMBOPOIETIN; THYMIDINE KINASE;

ANTIGEN EXPRESSION; CANCER GROWTH; CHRONIC LYMPHATIC LEUKEMIA; ENZYME BLOOD LEVEL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA CELL; MULTIVARIATE ANALYSIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ANTIGENS, CD38; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MUTATION; PROGNOSIS;

EID: 33751080728     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600947776     Document Type: Note

References (12)

1. Hamblin, T and Davis, Z and Gardiner, A and Oscier, D and Stevenson, F. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood, 94, pp. 1848-1854.
2. Damle, R and Wasil, T and Fais, F and Ghiotto, F and Valetto, A and Allen, S and (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood, 94, pp. 1840-1847.
3. Hamblin, T and Orchard, J and Davis, Z and Gardiner, A and Oscier, D and Stevenson, F. (2000) Immunoglobulin V genes and CD38 expression in CLL Blood, 95, pp. 2455-2457.
4. Wiestner, A and Rosenwald, A and Barry, T and Wright, G and Davis, R and Henrickson, S and (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome and distinct gene expression profile Blood, 101, pp. 4944-4951.
5. Crespo, M and Bosch, F and Villamor, N and Bellosillo, B and Colomer, D and Rozman, M and (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med, 348, pp. 1764-1775.
6. Orchard, J and Ibbotson, R and Davis, Z and Wiestner, A and Rosenwald, A and Thomas, P and (2004) ZAP-70 expression by flow cytometry is a good prognostic marker in CLL and a potential surrogate for immunoglobulin VH gene mutations Lancet, 363, pp. 105-111.
7. Rassenti, L and Huynh, L and Toy, T and Chen, L and Keating, M and Gribben, J and (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med, 351, pp. 893-901.
8. Del Principe, M and Del Poeta, G and Buccisano, F and Maurillo, L and Venditti, A and Zucchetto, A and (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia Blood, 108, pp. 853-861.
9. Hayat, A and O'Brien, D and O'Rourke, P and McGuckin, S and Fitzgerald, T and Conneally, E and (2006) CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia Leuk Lymph, 47(11), pp. 2371-2379.
10. Dohner, H and Stilgenbauer, S and Benner, A and Leupolt, E and Krober, A and Bullinger, L and (2000) Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med, 343, pp. 1910-1916.
11. Kröber, A and Bloehdorn, J and Hafner, S and Buhler, A and Seiler, T and Kienle, D and (2006) Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia J Clin Oncol, 24, pp. 969-975.
12. Chaar, B and Grosso, L and Petruska, P. (2006) Variability of ZAP 70 expression in a patient with CLL Am J Hematol, 81, pp. 645.